Position in OGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,812,204
+$5,626,655 QoQ
Shares Held
503,117
+636.7% QoQ
Ownership
0.192%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#66
of 626 holders
Holding Since
Jun 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New York Life Investment Management LLC holds $449,768,876 across 10 Drug Manufacturers - General names. OGN ranks #9 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
129,708 | $155,575,679 | |
| 2 | JNJ |
Johnson & Johnson
|
335,320 | $85,161,220 | |
| 3 | ABBV |
AbbVie Inc.
|
246,242 | $61,964,336 | |
| 4 | MRK |
Merck & Co., Inc.
|
343,960 | $44,198,860 | |
| 5 | AMGN |
Amgen Inc
|
86,677 | $31,387,475 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
184,378 | $23,294,316 | |
| 7 | PFE |
Pfizer Inc
|
794,237 | $19,125,226 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
303,600 | $17,493,432 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,812,204 | 503,117 | Shares | Sole | 2026-08-10 | |
| 2023-09-30 | $1,185,549 | 68,292 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,034,297 | 49,702 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $880,376 | 37,431 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,039,107 | 37,204 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $944,821 | 40,377 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,353,915 | 40,116 | Shares | Sole | 2022-08-12 | |
| No filing history on record for this holder in this stock. | ||||||